Your browser doesn't support javascript.
loading
Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models.
Heredia-Soto, Victoria; Escudero, Javier; Miguel, María; Ruiz, Patricia; Gallego, Alejandro; Berjón, Alberto; Hernández, Alicia; Martínez-Díez, Marta; Zheng, Shuyu; Tang, Jing; Hardisson, David; Feliu, Jaime; Redondo, Andrés; Mendiola, Marta.
Afiliación
  • Heredia-Soto V; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Escudero J; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • Miguel M; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Ruiz P; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Gallego A; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Berjón A; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
  • Hernández A; Department of Pathology, Hospital Universitario La Paz, Madrid, Spain.
  • Martínez-Díez M; Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Zheng S; Department of Obstetrics and Gynecology, Hospital Universitario La Paz, Madrid, Spain.
  • Tang J; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Hardisson D; Cell Biology Department, Research and Development, Oncology Business Unit, Pharmamar, Madrid, Spain.
  • Feliu J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Redondo A; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Mendiola M; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Front Oncol ; 12: 862321, 2022.
Article en En | MEDLINE | ID: mdl-35372006
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza